Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Blood Cancer Journal|August 8, 2020
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaKitsada Wudhikarn, M Lia Palomba, Martina Pennisi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Bone Marrow Transplantation|November 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Blood Advances|November 21, 2022
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantationMichael Scordo, Leah J Gilbert, Danielle M Hanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple MyelomaSusan Bal, Heather J Landau, Gunjan L Shah, et al.
Haematologica|July 16, 2016
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemiaCatherine C Coombs, David A Sallman, Sean M Devlin, et al.
Blood Advances|July 23, 2021
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformationOscar B Lahoud, Sean M Devlin, Molly A Maloy, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Blood Cancer Journal|August 8, 2020
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaKitsada Wudhikarn, M Lia Palomba, Martina Pennisi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Bone Marrow Transplantation|November 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Blood Advances|November 21, 2022
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantationMichael Scordo, Leah J Gilbert, Danielle M Hanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple MyelomaSusan Bal, Heather J Landau, Gunjan L Shah, et al.
Haematologica|July 16, 2016
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemiaCatherine C Coombs, David A Sallman, Sean M Devlin, et al.
Blood Advances|July 23, 2021
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformationOscar B Lahoud, Sean M Devlin, Molly A Maloy, et al.
Pageof 18